IN SILICO DISCOVERY OF NDM-1 METALLO--LACTAMASE INHIBITORS. Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: LAP LAMBERT Academic Publishing, 2026
- Softcover
- Neu

Anbieter: PBShop.store US, Wood Dale, IL, USAPBShop.store US
Verkäufer/-in mit 5 Sternen
Verkäufer:in bei ZVAB seit 7. April 2005
Nicht verfügbar
Softcover
Zustand: Neu
EUR 61,59
Artikelbeschreibung des Verkäufers
New Book. Shipped from UK. Established seller since 2000.
Bestandsnummer des Verkäufers L2-9786630056426
- Titel
- IN SILICO DISCOVERY OF NDM-1 METALLO--LACTAMASE INHIBITORS
- Autor
- S, Raghavendra
- Verlag
- LAP LAMBERT Academic Publishing
- Erscheinungsjahr
- 2026
- Zustand
- New
- Einband
- PAP
- Sprache
- Englisch
- ISBN-10
- 6630056426
- ISBN-13
- 9786630056426
- Artikelgewicht
- 96 Gramm
This book presents a comprehensive in silico drug discovery study focused on identifying potential inhibitors of New Delhi metallo-ß-lactamase-1 (NDM-1), a key enzyme responsible for extensive ß-lactam antibiotic resistance in Klebsiella pneumoniae. The work addresses the growing global threat of antimicrobial resistance and emphasizes the urgent need for novel therapeutic strategies against NDM-1-producing pathogens.The study follows a systematic computational workflow that includes protein retrieval and active-site identification, molecular docking, virtual screening, ADMET and toxicity prediction, and molecular dynamics (MD) simulations. The crystal structure of NDM-1 (PDB ID: 6NY7) was used as the target protein, and docking model validation was performed using the native ligand interactions.The findings conclude that the identified sulfonamide derivatives exhibit strong binding affinity, favorable ADME profiles, low toxicity, and stable interaction with NDM-1. The book establishes these compounds as potential lead candidates for further experimental validation and development against infections caused by NDM-1-producing Klebsiella pneumoniae.
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Raghavendra S is pursuing a Master's degree in Bioinformatics, Garden City University, Bengaluru. He holds a Bachelor of Pharmacy degree from Mallige College of Pharmacy, Rajiv Gandhi University of Health Sciences. His academic interests include computational drug discovery, molecular docking, virtual screening, molecular dynamics simulations, etc.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.